Alembic Pharmaceuticals has reported results for third quarter ended December 31, 2013.
The company has reported 38.44% rise in its net profit at Rs 67.84 crore for the quarter as compared to Rs 49 crore for the same quarter in the previous year. Total income from operations of the company has increased by 29.07% at Rs 476.60 crore for quarter under review as compared to Rs 369.24 crore for the quarter ended December 31, 2012.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.
The company has reported 38.44% rise in its net profit at Rs 67.84 crore for the quarter as compared to Rs 49 crore for the same quarter in the previous year. Total income from operations of the company has increased by 29.07% at Rs 476.60 crore for quarter under review as compared to Rs 369.24 crore for the quarter ended December 31, 2012.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.
No comments:
Post a Comment